To extend our understanding of finding different molecular mechanisms and pathways related to FUS and SOD1 mutation in ALS disease, we have performed a comprehensive gene expression profiling study using microarray hybridization of the iPSC-derived MN models from control individuals and compared with those from FUS-ALS and SOD1-ALS patients. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.